Task: Answer the multiple-choice question.
Question: Which compound exhibits a 1.874% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CC(C)Cn1c(N)c(C(=O)NCc2cccs2)c2nc3ccccc3nc21
b) CCOC(=O)NCCc1ccc(OC)cc1
c) C=CCN(c1ccc(C(N)=O)cc1)S(C)(=O)=O
Answer: a. CC(C)Cn1c(N)c(C(=O)NCc2cccs2)c2nc3ccccc3nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Cn1c(N)c(C(=O)NCc2cccs2)c2nc3ccccc3nc21
CC(C)Cn1c(N)c(C(=O)NCc2cccs2)c2nc3ccccc3nc21
2-amino-1-(2-methylpropyl)-N-(thiophen-2-ylmethyl)pyrrolo[3,2-b]quinoxaline-3-carboxamide